CURA is a WINNER!! As Curaleaf expands its operations, the company's results will likely only get better. Here's how it has done in terms of the past four quarters when looking at both its sales and adjusted EBITDA -- what cannabis companies usually rely on as a kinder measure of profitability:
| PERIOD ENDING | TOTAL REVENUE | YOY GROWTH RATE | ADJUSTED EBITDA |
| March 31, 2021 | $260 million | 170% | $63 million |
| Dec. 31, 2020 | $230 million | 184% | $54 million |
| Sep. 30, 2020 | $182 million | 195% | $42 million |
| June 30, 2020 | $117 million | 142% | $28 million |
Data source: Company filings. YOY = year over year.
If Curaleaf can continue growing not just its revenue but its bottom line, there's little doubt that the stock can be a long-term buy that will make you rich over the years.
https://www.msn.com/en-us/money/topstocks/2-cannabis-stocks-that-could-make-you-rich/ar-AAMqKlL